Optimization of therapies for men with advanced prostate cancer: a review of recent developments with a look toward the future
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Oncology
Reference41 articles.
1. Improved survival for patients with de novo metastatic prostate cancer in the last 20 years;Berg;Eur J Cancer,2017
2. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019
3. Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center;Denis;Eur Urol,1998
4. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial;Kyriakopoulos;J Clin Oncol,2018
5. Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy;James;N Engl J Med,2017
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of icariin and curcumol on autophagy, ferroptosis, and lipid metabolism based on miR ‐7/ m‐TOR / SREBP1 pathway on prostate cancer;BioFactors;2022-12-30
2. Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR‑9;Oncology Reports;2021-09-28
3. A novel 1-((3-(2-toluyl)-4,5-dihydroisoxazol-5-yl)methyl)-4-(trifluoromethyl)pyrimidin-2(1H)-one activates intrinsic mitochondria-dependent pathway and decreases angiogenesis in PC-3 cells;European Journal of Pharmacology;2021-05
4. What Do Men with Metastatic Prostate Cancer Consider When Making Treatment Decisions? A Mixed-methods Study;Patient Preference and Adherence;2020-10
What Do Men with Metastatic Prostate Cancer Consider When Making Treatment Decisions? A Mixed-methods Study
5. Safety and activity of radium-223 in metastatic castration-resistant prostate cancer: the experience of Istituto Nazionale dei Tumori;Tumori Journal;2020-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3